205 related articles for article (PubMed ID: 27934599)
1. Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9.
Guo D; Liu H; Gao G; Ruzi A; Wang K; Wu H; Lai K; Liu Y; Yang F; Lai L; Li YX
Stem Cell Res; 2016 Nov; 17(3):640-642. PubMed ID: 27934599
[TBL] [Abstract][Full Text] [Related]
2. Generation of an Abcc8 heterozygous mutation human embryonic stem cell line using CRISPR/Cas9.
Guo D; Liu H; Gao G; Ruzi A; Wang K; Wu H; Lai K; Liu Y; Yang F; Lai L; Li YX
Stem Cell Res; 2016 Nov; 17(3):670-672. PubMed ID: 27934605
[TBL] [Abstract][Full Text] [Related]
3. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
[TBL] [Abstract][Full Text] [Related]
4. Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9.
Guo D; Liu H; Ruzi A; Gao G; Nasir A; Liu Y; Yang F; Wu F; Xu G; Li YX
Sci Rep; 2017 Jun; 7(1):3156. PubMed ID: 28600547
[TBL] [Abstract][Full Text] [Related]
5. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
[TBL] [Abstract][Full Text] [Related]
6. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):308-10. PubMed ID: 27345991
[TBL] [Abstract][Full Text] [Related]
7. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9.
Yuan F; Guo D; Gao G; Liu Y; Xu Y; Wu Y; Yang F; Ke X; Lai K; Hong L; Li YX
Stem Cell Res; 2017 Oct; 24():89-93. PubMed ID: 29034901
[TBL] [Abstract][Full Text] [Related]
8. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
[TBL] [Abstract][Full Text] [Related]
9. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9.
Xu Y; Wu Y; Guo D; Gao G; Lai K; Yang F; Wang K; Wu H; Lai L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jul; 22():29-32. PubMed ID: 28952928
[TBL] [Abstract][Full Text] [Related]
10. Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing.
Giri S; Purushottam M; Viswanath B; Muddashetty RS
Stem Cell Res; 2019 Aug; 39():101494. PubMed ID: 31280136
[TBL] [Abstract][Full Text] [Related]
11. SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism.
Lithovius V; Saarimäki-Vire J; Balboa D; Ibrahim H; Montaser H; Barsby T; Otonkoski T
Diabetologia; 2021 Mar; 64(3):630-640. PubMed ID: 33404684
[TBL] [Abstract][Full Text] [Related]
12. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
[TBL] [Abstract][Full Text] [Related]
13. A homozygous Keap1-knockout human embryonic stem cell line generated using CRISPR/Cas9 mediates gene targeting.
Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
Stem Cell Res; 2017 Mar; 19():52-54. PubMed ID: 28413007
[TBL] [Abstract][Full Text] [Related]
14. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism -a case report.
Üstün NU; Dilli D; Kundak AA; Okumus N; Erdoğan D; Apaydın S
Fetal Pediatr Pathol; 2013 Dec; 32(6):412-7. PubMed ID: 23607867
[TBL] [Abstract][Full Text] [Related]
16. Generation of FHL2 homozygous knockout lines from human embryonic stem cells by CRISPR/Cas9-mediated ablation.
Chang CW; Chang CC; Hsia KC; Tsai SY
Stem Cell Res; 2018 Mar; 27():21-24. PubMed ID: 29291512
[TBL] [Abstract][Full Text] [Related]
17. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11.
Fournet JC; Mayaud C; de Lonlay P; Gross-Morand MS; Verkarre V; Castanet M; Devillers M; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
Am J Pathol; 2001 Jun; 158(6):2177-84. PubMed ID: 11395395
[TBL] [Abstract][Full Text] [Related]
18. Generation of human embryonic stem cells from abnormal blastocyst diagnosed with albinism.
Sun Y; Zhou X; Chen J; Du J; Lu G; Lin G; Ouyang Q
Stem Cell Res; 2016 Nov; 17(3):643-645. PubMed ID: 27934600
[TBL] [Abstract][Full Text] [Related]
19. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Yan FF; Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
Diabetes; 2007 Sep; 56(9):2339-48. PubMed ID: 17575084
[TBL] [Abstract][Full Text] [Related]
20. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
